HemostOD SA
PrivateLast Round
Grant
Feb 3, 2026
Total Funding Raised
$10.64M
Company Overview
HemostOD SA operates in Healthcare & Life Sciences and is based in Saint-Sulpice. Its latest recorded funding round was a Grant round in February 2026.
HemostOD SA is a biotechnology company that develops a proprietary platform for the ex vivo manufacturing of donor-free, universal human blood platelets for transfusion and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemostOD SA Comparables
Compare HemostOD SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HemaCell (Xueji Bio) | 79% | |
| DewCell Inc. | 78% | |
| Sysmex Corporation | 75% |
For institutional investors. Book with your work email.
HemostOD SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 3, 2026 | ||||
| Seed | Oct 1, 2025 | ||||
| Debt | Jun 11, 2024 | ||||
| Debt | May 3, 2022 | ||||
| Seed | Sep 7, 2021 | ||||
Accelerator | Apr 29, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HemostOD SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Technological Innovation | Debt |
| Innosuisse | Grant |
| Venture Kick | Accelerator |
| PolyTech Ventures | Seed |
| Lichtsteiner Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 412% MoM, from 59 to 302.
- Apr 9, 2026
Grew 43% QoQ, from 7 to 10 employees.
For institutional investors. Book with your work email.
HemostOD SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HemostOD SA's valuation, stock price, and market status.
Is HemostOD SA a public or private company?
HemostOD SA is a private company.
What is the current stock price of HemostOD SA?
HemostOD SA is a private company, so its shares have no public market price. Caplight tracks HemostOD SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HemostOD SA worth (valuation)?
Valuation information for HemostOD SA is not publicly available.
Can I buy HemostOD SA stock?
HemostOD SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HemostOD SA's last funding round?
HemostOD SA's most recent funding round was Grant on February 3, 2026.
Who are the main investors in HemostOD SA?
Key investors in HemostOD SA include PolyTech Ventures.
Will HemostOD SA IPO soon?
No public IPO plans have been announced for HemostOD SA.
How can I track HemostOD SA secondary market activity?
Caplight tracks bids, offers, and trades in HemostOD SA's shares on secondary markets.